The chances of surviving oral cancer can now be predicted from AI algorithms by measuring immune cells in tumors.

Emerging technologies like AI and robotics have vast potential to improve healthcare. Few question this. What remains unclear is how meaningful the advances will be to healthcare providers and, more to the point, the patients they serve.

Civica Rx, a not-for-profit drug company with $100 million in funding that aims to combat drug shortages, has inked its next deal with Exela Pharma Sciences to supply its membership of hospitals with sodium bicarbonate injections.

Two major companies are joining forces in a 10-year strategic partnership to accelerate healthcare innovation through digital technologies.

Geisinger has tapped IBM’s AI expertise and come up with a way to predict hospital patients’ risk of sepsis. In the process, the method can increase chances of survival in those who have the tricky and potentially life-threatening condition.

A single heartbeat is all a new neural-network technique needs to detect heart failure with 100% accuracy, according to a study slated for January 2020 publication in Biomedical Signal Processing and Control Journal.

Chicago biotech company BIOLIFE4D announced this week it had successfully 3D-bioprinted a mini human heart—something the company noted as a “significant milestone” on the path to printing full-sized hearts viable for transplant.

Proven protocols and practices, people and a push for earlier hemodynamic support are changing the face of cardiogenic shock survival. One leading health system has improved survival rates into the 70+ percent range. And their team believes other facilities should follow suit.